Creative Financial Designs Inc Omeros Corp Transaction History

Creative Financial Designs Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$1.08 - $3.63 $540 - $1,815	500 Added 16.39%	3,550 $11,000
Q3 2023 Nov 14, 2023	SELL	$2.81 - $5.69 $8,430 - $17,070	-3,000 Reduced 49.59%	3,050 $8,000
Q3 2022 Nov 01, 2022	BUY	$3.09 - $7.46 $9,424 - $22,753	3,050 Added 101.67%	6,050 $19,000
Q2 2022 Aug 01, 2022	BUY	$1.92 - $6.28 $5,760 - $18,840	3,000 New	3,000 $8,000
Q1 2022 Apr 15, 2022	SELL	$5.07 - $7.2 $44,362 - $63,000	-8,750 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$5.67 - $8.54 $11,340 - $17,080	2,000 Added 29.63%	8,750 $56,000
Q3 2021 Oct 08, 2021	BUY	$13.4 - $16.3 $22,110 - $26,895	1,650 Added 32.35%	6,750 $93,000
Q1 2021 Apr 19, 2021	BUY	$14.52 - $23.53 $74,052 - $120,003	5,100 New	5,100 $91,000
Q3 2020 Oct 06, 2020	SELL	$9.57 - $21.32 $1,818 - $4,050	-190 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$12.21 - $16.99 $2,319 - $3,228	190 New	190 $3,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $423M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.